SCHEMBL12428258

SCHEMBL12428258

Cc1ccc(N2CCCc3cc(-c4ccc(C5=C/C(=C6\C(=O)N(c7ccccc7)N=C6C(=O)O)CCC5)s4)ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SCN9A Q15858 2/20 0.36
CREBBP Q92793 1/20 0.34
ACHE P22303 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
USP2 O75604 1/20 0.31
TSHR P16473 1/20 0.31
TP53 P04637 1/20 0.31
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
OPRK1 P41145 1/20 0.31
KCNQ2 O43526 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428342 0.84 SCN9A (0.49) SCN9AACHE
SCHEMBL12428261 0.82 EP300 (0.40) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL12428264 0.82 EP300 (0.40) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL12428249 0.82 EP300 (0.41) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL12428259 0.82 SCN9A (0.39) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL14289374 0.80 ALDH1A1 (0.37) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL12428273 0.77 SCN9A (0.36) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL12428272 0.75 SCN9A (0.36) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL12428451 0.74 SCN9A (0.38) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL12428372 0.73 OPRM1 (0.45) MAPTALDH1A1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 MAPT 4642/4885ALDH1A1 235/4885LMNA 3136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.